Leading Driver in the Automated Microbiology Market 2025: Surge In Rapid & Accurate Diagnostics Fueling Market Growth

June 13, 2025 01:39 PM BST | By EIN Presswire
 Leading Driver in the Automated Microbiology Market 2025: Surge In Rapid & Accurate Diagnostics Fueling Market Growth
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, June 13, 2025 /EINPresswire.com/ -- What Does The Data On The Automated Microbiology Market Size Indicate? And What Does The Future Hold For The Automated Microbiology Market?

In a recent global market report, the automated microbiology industry reveals astonishing projected growth with an expected market size reaching $9.43 billion in 2025 and rising to $15.38 billion by 2029. This notable expansion representing a compound annual growth rate CAGR of 13.2% in the historical period and projected 13.0% over the forecast period.

What Are The Key Drivers For Growth In The Automated Microbiology Market?

Serving as key drivers behind the market's expansion are factors including the increasing prevalence of infectious diseases, growing demand for early diagnosis, the rise of rapid diagnostic testing, the surge of hospital-acquired infections, and significant government support for microbial surveillance. Further supporting the market's growth are projections of more rapid developments unfolding in the next few years, including an established shift towards full automation in clinical diagnostics, a rise in the global geriatric population, escalating demands for point-of-care diagnostics, the expansion of hospital infrastructure, and a growing necessity for antimicrobial resistance detection.

The industry is expected to benefit further from the adoption of lab-on-a-chip technology, advancements with cloud-based data analysis, the integration of artificial intelligence AI and machine learning ML systems, and the development of portable automated analyzers. To gain a more detailed understanding of these trends,

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24163&type=smp

Adding fuel to the fire is the rampant rise in demand for rapid and accurate diagnostic solutions. This growth driver is attributed to an increasing necessity for timely disease detection to prevent complications and enhance patient outcomes. Automated microbiology is rising to meet this demand, providing high-throughput, standardized and error-minimized testing that ensures faster results and better patient care. This demand was highlighted by the Global Fund in a report released in January 2024, which showed that diagnosed tuberculosis cases using WHO-recommended diagnostic tools leaped from 38% in 2021 to 47% in 2022. These figures underline the shifted preference towards automated diagnostics as a game-changing advancement.

Which Companies Are Leading The Automated Microbiology Market?

Key industry players playing a significant role in the automated microbiology market includes prominent names such as Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Agilent Technologies Inc., Charles River Laboratories, PerkinElmer Inc., bioMérieux SA, Sysmex Corporation, BioRad Laboratories, HORIBA Ltd., DiaSorin S.p.A., Neogen Corporation, Orchard Software Corporation​, Era Biology Group, Rapid Micro Biosystems Inc., Avails Medical Inc., Hudson Lab Automation, and Shenzhen YHLO Biotech Co. Ltd.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/automated-microbiology-global-market-report

What Are The Emerging Trends In The Automated Microbiology Market?

Continuing to push the boundaries of innovation, major companies in this market are exploring advanced solutions like matrix-assisted laser desorption or ionization MALDI biotyper systems to further enhance the speed and accuracy of microbial identification. The launch of the MBT Pathfinder IVD robot for automated MALDI Biotyper target preparation by Bruker Corporation in April 2024 marks an important development as it revolutionizes the preparation of targets for MALDI Biotyper analysis.

How Is The Automated Microbiology Market Segmented?
The market segmentation for the global automated microbiology industry is outlined as such:

- By Product: Instruments, Reagents And Kits, Software
- By Automation Type: Fully Automated, Semi-Automated
- By Diagnostic Technology: DNA Sequencing, DNA And RNA Probe Technology, Detection Techniques, Monoclonal Antibodies, Immunoassays
- By Application: Biopharmaceutical Production, Clinical Diagnostics, Environmental And Water Testing, Food And Beverage Testing, Other Applications
- By End Use: Pharmaceutical And Biotechnology Companies, Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Other End Uses

These primary classifications expand further into numerous subsegments which provide an in-depth perspective into the conclusive reach of the automated microbiology sector.

What Are The Key Regional Insights Into The Automated Microbiology Market?
On a geographical note, North America led as the largest region in the automated microbiology market in 2024 with the market report casting a wide net over the other contributing regions which include Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:

Clinical Microbiology Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/clinical-microbiology-global-market-report

Industrial Microbiology Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/industrial-microbiology-global-market-report

Pharma Microbiology Testing Kits Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pharma-microbiology-testing-kits-global-market-report

The Business Research Company, with more than 15000+ reports from 27 industries spanning across 60+ geographies, has established a name in providing comprehensive, data-rich research and insights. With over 1,500,000 datasets, a reassuring contribution from in-depth secondary research, and novel insights from industry leaders, we equip you with the information you need to remain at the forefront of your industry.

Contact us at
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Sponsored Articles


Investing Ideas

Previous Next